MAR 06, 2018 8:00 AM PST

Performance assessment of RNA sequencing and expression arrays for transcriptome analysis in cancer research

Speaker
  • Research Scientist, Bioinformatics and Modelling Group, Proteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health
    Biography
      Dr. Petr Nazarov is a Research Scientist in the Proteome and Genome Research Unit of the Department of Oncology at Luxembourg Institute of Health and an invited Assistant Professor at Luxembourg University. Dr. Nazarov produced over 30 publications devoted to data analysis and oncology. His primary expertise is biostatistics, machine learning and genomics. His recent work focuses on characterizing transcriptional variations in peritumoral tissue environment of pancreatic cancer, as well as tumors originated from lung, colon, skin and brain. His current research leverages deconvolution of transcriptomic signals from heterogeneous tumors to improve cancer classification.

    Abstract

    DATE: March 6, 2018
    TIME: 08:00am PST, 11:00am EST, 5:00pm CET

    RNA sequencing and expression arrays are transcriptomics techniques used to quantify transcribed genes and their isoforms. The first part of the talk will compare RNA-seq and array performance for the analysis of differences between normal lung epithelium tissue and squamous cell carcinoma lung tumors. High concordance for protein-coding gene expression was observed between the platforms. However, much more discrepant results were obtained for the detection of less abundant transcripts, including long non-coding RNAs and alternatively spliced variants. The second part of the talk will describe the method that can help combine results from different platforms and analyze data generated from bulk heterogeneous samples, called independent component analysis.

    In this webinar, the speaker will:

    • Describe the results of platform comparison for protein-coding and long non-coding genes
    • Explain the biases observed in RNA-seq and expression array platforms
    • Share insights on how deconvolution of transcriptomics data followed by machine learning can improve tumor classification

     

    For Research Use Only. Not for use in diagnostic procedures.


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    DEC 10, 2019 9:00 AM PST
    C.E. CREDITS
    DEC 10, 2019 9:00 AM PST
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    Loading Comments...
    Show Resources
    Attendees
    • See more